Users' questions

How long do you treat hospital acquired pneumonia?

How long do you treat hospital acquired pneumonia?

Traditionally, nosocomial pneumonias have been treated for 7-14 days. However, ventilator-associated pneumonia (VAP) (except due to nonfermenting gram-negative rods [eg, P aeruginosa]) can be successfully treated in 7 days).

What is VTE protocol?

The VTE protocol consists of a standardized VTE risk assessment with a linked menu of appropriate prophylaxis options (plus a method to determine contraindications to pharmacologic VTE prophylaxis).

When do you order DVT prophylaxis?


  • Elderly (older than 70)
  • Immobile patients.
  • History of DVT/PE.
  • Critical ill patients admitted to intensive care unit (ICU)
  • Stroke with lower extremity paralysis.
  • Advanced congestive heart failure (CHF)
  • Active cancer.
  • Acute respiratory failure.

How long should antibiotic therapy last for hospital acquired pneumonia?

In patients who receive an initially appropriate antibiotic regimen, efforts should be made to shorten the duration of therapy from the traditional 14 to 21 days to periods as short as 7 to 8 days. 19 Longer durations of treatment may be required if MDROs are present.

How long should DVT patients be on anticoagulation?

The guidelines favor shorter courses of anticoagulation (3-6 months) for acute DVT/PE associated with a transient risk factor. The guidelines suggest indefinite anticoagulation for most patients with unprovoked DVT/PE or a DVT/PE associated with a chronic risk factor.

Can a patient with DVT be treated at home?

This does not apply to patients who have other reasons for hospitalization, who lack support at home, who cannot afford medications, or who present with limb-threatening DVT or at high risk for bleeding. The ASH guidelines suggest offering home treatment instead of hospitalization for patients with acute PE at low risk for complications.

What are the ash guidelines for DVT treatment?

The ASH guidelines suggest against the routine use of prognostic scores, D-dimer testing, or venous ultrasound to guide the duration of anticoagulation. For patients with breakthrough DVT and/or PE while on therapeutic VKA treatment, the ASH guidelines suggest using low molecular weight heparin over DOAC therapy.